Schuurs-Hoeijmakers syndrome in two patients from Japan

Yusuke Hoshino, Takashi Enokizono, Kazuo Imagawa, Ryuta Tanaka, Hisato Suzuki, Hiroko Fukushima, Junichi Arai, Ryo Sumazaki, Tomoko Uehara, Toshiki Takenouchi, Kenjiro Kosaki

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Schuurs-Hoeijmakers syndrome is a rare disease characterized by intellectual disability and dysmorphic facial features among various physical abnormalities due to PACS1 mutation. To date, 28 patients with a recurrent de novo PACS1 mutation (c.607C > T) have been reported, primarily in Western populations. Here, we describe two Japanese patients with Schuurs-Hoeijmakers syndrome with a recurrent PACS1 mutation. In addition to the typical clinical symptoms, each patient presented novel clinical phenotypes. One patient presented with involuntary movements and was treated with trihexyphenidyl hydrochloride. We hypothesized that the PACS1 mutation leads to an inherent dopaminergic insufficiency that underlies the developing symptoms along with the neurodevelopmental processes. The second patient was diagnosed with lipomyelomeningocele during an examination for severe constipation at the age of 2 years and 8 months. The diagnosis of lipomyelomeningocele in this patient was delayed due to the lack of cutaneous lesions. As the majority of patients with PACS1 mutation present constipation, underdiagnosis of lipomyelomeningocele is a possibility. As the phenotypic expansion of the patients with Schuurs-Hoeijmakers syndrome was not fully recognized, additional studies are needed to clarify the clinical spectrum.

Original languageEnglish
Article numbere9
JournalAmerican Journal of Medical Genetics, Part A
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Japan
Mutation
Constipation
Trihexyphenidyl
Dyskinesias
Rare Diseases
Intellectual Disability
Phenotype
Skin
Population
Lipomyelomeningocele

Keywords

  • c.607C > T
  • lipomyelomeningocele
  • PACS1
  • Schuurs-Hoeijmakers syndrome

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Hoshino, Y., Enokizono, T., Imagawa, K., Tanaka, R., Suzuki, H., Fukushima, H., ... Kosaki, K. (Accepted/In press). Schuurs-Hoeijmakers syndrome in two patients from Japan. American Journal of Medical Genetics, Part A, [e9]. https://doi.org/10.1002/ajmg.a.9

Schuurs-Hoeijmakers syndrome in two patients from Japan. / Hoshino, Yusuke; Enokizono, Takashi; Imagawa, Kazuo; Tanaka, Ryuta; Suzuki, Hisato; Fukushima, Hiroko; Arai, Junichi; Sumazaki, Ryo; Uehara, Tomoko; Takenouchi, Toshiki; Kosaki, Kenjiro.

In: American Journal of Medical Genetics, Part A, 01.01.2018.

Research output: Contribution to journalArticle

Hoshino Y, Enokizono T, Imagawa K, Tanaka R, Suzuki H, Fukushima H et al. Schuurs-Hoeijmakers syndrome in two patients from Japan. American Journal of Medical Genetics, Part A. 2018 Jan 1. e9. https://doi.org/10.1002/ajmg.a.9
Hoshino, Yusuke ; Enokizono, Takashi ; Imagawa, Kazuo ; Tanaka, Ryuta ; Suzuki, Hisato ; Fukushima, Hiroko ; Arai, Junichi ; Sumazaki, Ryo ; Uehara, Tomoko ; Takenouchi, Toshiki ; Kosaki, Kenjiro. / Schuurs-Hoeijmakers syndrome in two patients from Japan. In: American Journal of Medical Genetics, Part A. 2018.
@article{1ffc38a9be034fbabb0af094fc69700a,
title = "Schuurs-Hoeijmakers syndrome in two patients from Japan",
abstract = "Schuurs-Hoeijmakers syndrome is a rare disease characterized by intellectual disability and dysmorphic facial features among various physical abnormalities due to PACS1 mutation. To date, 28 patients with a recurrent de novo PACS1 mutation (c.607C > T) have been reported, primarily in Western populations. Here, we describe two Japanese patients with Schuurs-Hoeijmakers syndrome with a recurrent PACS1 mutation. In addition to the typical clinical symptoms, each patient presented novel clinical phenotypes. One patient presented with involuntary movements and was treated with trihexyphenidyl hydrochloride. We hypothesized that the PACS1 mutation leads to an inherent dopaminergic insufficiency that underlies the developing symptoms along with the neurodevelopmental processes. The second patient was diagnosed with lipomyelomeningocele during an examination for severe constipation at the age of 2 years and 8 months. The diagnosis of lipomyelomeningocele in this patient was delayed due to the lack of cutaneous lesions. As the majority of patients with PACS1 mutation present constipation, underdiagnosis of lipomyelomeningocele is a possibility. As the phenotypic expansion of the patients with Schuurs-Hoeijmakers syndrome was not fully recognized, additional studies are needed to clarify the clinical spectrum.",
keywords = "c.607C > T, lipomyelomeningocele, PACS1, Schuurs-Hoeijmakers syndrome",
author = "Yusuke Hoshino and Takashi Enokizono and Kazuo Imagawa and Ryuta Tanaka and Hisato Suzuki and Hiroko Fukushima and Junichi Arai and Ryo Sumazaki and Tomoko Uehara and Toshiki Takenouchi and Kenjiro Kosaki",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/ajmg.a.9",
language = "English",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",

}

TY - JOUR

T1 - Schuurs-Hoeijmakers syndrome in two patients from Japan

AU - Hoshino, Yusuke

AU - Enokizono, Takashi

AU - Imagawa, Kazuo

AU - Tanaka, Ryuta

AU - Suzuki, Hisato

AU - Fukushima, Hiroko

AU - Arai, Junichi

AU - Sumazaki, Ryo

AU - Uehara, Tomoko

AU - Takenouchi, Toshiki

AU - Kosaki, Kenjiro

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Schuurs-Hoeijmakers syndrome is a rare disease characterized by intellectual disability and dysmorphic facial features among various physical abnormalities due to PACS1 mutation. To date, 28 patients with a recurrent de novo PACS1 mutation (c.607C > T) have been reported, primarily in Western populations. Here, we describe two Japanese patients with Schuurs-Hoeijmakers syndrome with a recurrent PACS1 mutation. In addition to the typical clinical symptoms, each patient presented novel clinical phenotypes. One patient presented with involuntary movements and was treated with trihexyphenidyl hydrochloride. We hypothesized that the PACS1 mutation leads to an inherent dopaminergic insufficiency that underlies the developing symptoms along with the neurodevelopmental processes. The second patient was diagnosed with lipomyelomeningocele during an examination for severe constipation at the age of 2 years and 8 months. The diagnosis of lipomyelomeningocele in this patient was delayed due to the lack of cutaneous lesions. As the majority of patients with PACS1 mutation present constipation, underdiagnosis of lipomyelomeningocele is a possibility. As the phenotypic expansion of the patients with Schuurs-Hoeijmakers syndrome was not fully recognized, additional studies are needed to clarify the clinical spectrum.

AB - Schuurs-Hoeijmakers syndrome is a rare disease characterized by intellectual disability and dysmorphic facial features among various physical abnormalities due to PACS1 mutation. To date, 28 patients with a recurrent de novo PACS1 mutation (c.607C > T) have been reported, primarily in Western populations. Here, we describe two Japanese patients with Schuurs-Hoeijmakers syndrome with a recurrent PACS1 mutation. In addition to the typical clinical symptoms, each patient presented novel clinical phenotypes. One patient presented with involuntary movements and was treated with trihexyphenidyl hydrochloride. We hypothesized that the PACS1 mutation leads to an inherent dopaminergic insufficiency that underlies the developing symptoms along with the neurodevelopmental processes. The second patient was diagnosed with lipomyelomeningocele during an examination for severe constipation at the age of 2 years and 8 months. The diagnosis of lipomyelomeningocele in this patient was delayed due to the lack of cutaneous lesions. As the majority of patients with PACS1 mutation present constipation, underdiagnosis of lipomyelomeningocele is a possibility. As the phenotypic expansion of the patients with Schuurs-Hoeijmakers syndrome was not fully recognized, additional studies are needed to clarify the clinical spectrum.

KW - c.607C > T

KW - lipomyelomeningocele

KW - PACS1

KW - Schuurs-Hoeijmakers syndrome

UR - http://www.scopus.com/inward/record.url?scp=85059096963&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059096963&partnerID=8YFLogxK

U2 - 10.1002/ajmg.a.9

DO - 10.1002/ajmg.a.9

M3 - Article

C2 - 30588754

AN - SCOPUS:85059096963

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

M1 - e9

ER -